Duchesnay Inc. announced results from a new study concluding that pre-emptive use of Diclectin(R) is effective in reducing symptoms of severe NVP in patients at high risk for recurrence of severe NVP. The study was conducted by Gideon Koren, M.D., and Caroline Maltepe, B.A., of The Motherisk Program more
To use all functions of this page, please activate cookies in your browser.
